Unknown

Dataset Information

A Randomized Controlled Trial of Norepinephrine Plus Dobutamine Versus Epinephrine As First-Line Vasoactive Agents in Children With Fluid Refractory Cold Septic Shock.


ABSTRACT: Our objective was to compare norepinephrine plus dobutamine versus epinephrine as the first-line agent in children with fluid refractory cold septic shock.

Design

Open-label randomized controlled study.

Setting

A single-center PICU from North India.

Patients

Children 2 months to less than 18 years old with fluid refractory cold septic shock.

Interventions

In the intervention group, norepinephrine and dobutamine were started and in the control group, epinephrine was started as the first-line vasoactive agent. The primary outcome was the proportion attaining shock resolution (attaining all the therapeutic endpoints) at 1 hour of therapy.

Measurements and main results

We enrolled 67 children: 34 in the norepinephrine plus dobutamine group (intervention) and

SUBMITTER: Banothu KK 

PROVIDER: S-EPMC9799172 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature